PF-04971729

CAS No. 1210344-57-2

PF-04971729( Ertugliflozin | MK-8835 | PF-4971729 )

Catalog No. M10784 CAS No. 1210344-57-2

A potent and selective SGLT2 inhibitor with IC50 of 0.877 nM for hSGLT2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
10MG 57 In Stock
50MG 87 In Stock
100MG 133 In Stock
200MG 214 In Stock
500MG 353 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-04971729
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective SGLT2 inhibitor with IC50 of 0.877 nM for hSGLT2.
  • Description
    A potent and selective SGLT2 inhibitor with IC50 of 0.877 nM for hSGLT2; shows >2000-fold selectivity over hSGLT1; demonstrates robust urinary glucose excretion in rats and an excellent preclinical safety profile.Diabetes Phase 3 Clinical(In Vitro):Ertugliflozin (PF-04971729) demonstrates >2000-fold selectivity for SGLT2 inhibition (relative to SGLT1) in vitro.(In Vivo):Ertugliflozin (PF-04971729) reveals a concentration-dependent glucosuria after oral administration to rats.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ertugliflozin | MK-8835 | PF-4971729
  • Pathway
    GPCR/G Protein
  • Target
    SGLT
  • Recptor
    SGLT2
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    1210344-57-2
  • Formula Weight
    436.8827
  • Molecular Formula
    C22H25ClO7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 46 mg/mL
  • SMILES
    O[C@@H]1[C@](O2)(CO)CO[C@]2(C3=CC=C(Cl)C(CC4=CC=C(C=C4)OCC)=C3)[C@H](O)[C@H]1O
  • Chemical Name
    β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mascitti V, et al. J Med Chem. 2011 Apr 28;54(8):2952-60. 2. Kalgutkar AS, et al. Drug Metab Dispos. 2011 Sep;39(9):1609-19. 3. Miao Z, et al. Drug Metab Dispos. 2013 Feb;41(2):445-56.
molnova catalog
related products
  • KGA-2727

    KGA-2727 is a potent and selective SGLT1 inhibitor, with Kis of 97.4 nM and 43.5 nM for human and rat SGLT1, respectively.?The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat).?KGA-2727 for the treatment of diabete.KGA-2727, which has a pyrazole-O-glucoside structure, as the first selective SGLT1 inhibitor.?

  • Canagliflozin

    A highly potent and selective SGLT2 inhibitor with IC50 of 4.4, 3.7 and 2.0 nM for hSGLT2, rSGLT2 and mSGLT2, respectively.

  • Licogliflozin

    A novel sodium glucose transporter type 1 and type 2 (SGLT1/2) inhibitor for the oral treatment of type 2 diabetes.